An Act to Amend the Prescription Drug Payment Act
Her Majesty, by and with the advice and consent of the Legislative Assembly of New Brunswick, enacts as follows:
1 Section 2.01 of the Prescription Drug Payment Act, chapter P-15.01 of the Acts of New Brunswick, 1975, is amended by adding after subsection (1) the following:
2.01(1.1) Subsection (1) does not apply to a person who has been diagnosed with multiple sclerosis by a neurologist and who has a prescription from a neurologist for the drug Avonex, Betaseron, Copaxone or Rebif for treatment of the multiple sclerosis.
2.01(1.2) Subsection (1.1) is limited in its effect to those entitled services to which a person diagnosed with multiple sclerosis is entitled under the programme.
2 The Act is amended by adding after section 7 the following:
7.1 A regulation made under section 7 may be made retroactive in its operation.
3 This Act shall be deemed to have come into force on February 8, 2000.
The existing provision is as follows:
2.01(1) Notwithstanding the definition "beneficiary", no person is eligible to receive benefits under the programme if the person has, or is covered by, a contract or plan of insurance that, in the opinion of the Minister, provides benefits similar to the benefits provided under the programme.
2.01(2) Notwithstanding the definition "beneficiary", no person is eligible to receive benefits under the programme if the person is eligible to receive a drug, good or service under the terms of a statute prescribed by regulation.
Regulations under the Act may be made retroactive in their operation.